ESPR · CIK 0001434868 · operating
Esperion Therapeutics, Inc. (ESPR) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $782 million, Esperion Therapeutics, Inc. is a small-cap company. The stock currently trades at $3.27, down 2.39% today, with a 52-week range of $0.69–$4.18. The company trades at a forward P/E of 33.8x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.28 | $-0.28 | +86.2% | |
| 2023 | $-2.03 | $-2.03 | +42.3% | |
| 2022 | $-3.52 | $-3.52 | +62.2% | |
| 2021 | $-9.31 | $-9.31 | -139.3% | |
| 2020 | $-3.89 | $-3.89 | -72.1% | |
| 2019 | $-2.26 | $-2.26 | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-07 | 0001628280-25-011154 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0001628280-24-007066 | SEC ↗ |
| 2022-12-31 | 2023-02-21 | 0001628280-23-004167 | SEC ↗ |
| 2021-12-31 | 2022-02-22 | 0001628280-22-003263 | SEC ↗ |
| 2020-12-31 | 2021-02-23 | 0001628280-21-002865 | SEC ↗ |
| 2019-12-31 | 2020-02-27 | 0001104659-20-026203 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001047469-19-000791 | SEC ↗ |
| 2017-12-31 | 2018-02-20 | 0001047469-18-000899 | SEC ↗ |
| 2016-12-31 | 2017-02-22 | 0001047469-17-000831 | SEC ↗ |
| 2015-12-31 | 2016-02-25 | 0001047469-16-010437 | SEC ↗ |
| 2014-12-31 | 2015-03-10 | 0001047469-15-001908 | SEC ↗ |
| 2013-12-31 | 2014-03-13 | 0001047469-14-002320 | SEC ↗ |